iSoMAs: Finding isoform expression and somatic mutation associations in human cancers
PLOS Computational Biology · 2025
DOI: 10.1371/journal.pcbi.1012847 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, 2025. Verfasst von Hua Tan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United Sta…. Hauptthemen laut MEDLINE: Neoplasms, Mutation, Alternative Splicing. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Intramural NIH HHS, NHGRI NIH HHS, Carlsberg Foundation.
Abstract (Originalsprache)
Aberrant alternative splicing, prevalent in cancer, impacts various cancer hallmarks involving proliferation, angiogenesis, and invasion. Splicing disruption often results from somatic point mutations rewiring functional pathways to support cancer cell survival. We introduce iSoMAs ( iSo form expression and somatic M utation A s sociation), an efficient computational pipeline leveraging principal component analysis technique, to explore how somatic mutations influence transcriptome-wide gene expression at the isoform level. Applying iSoMAs to 33 cancer types comprising 9,738 tumor samples in The Cancer Genome Atlas, we identified 908 somatically mutated genes significantly associated with altered isoform expression across three or more cancer types. Mutations linked to differential isoform expression occurred through both cis - and trans -acting mechanisms, involving well-known oncogenes/suppressor genes, RNA binding protein and splicing factor genes. With wet-lab experiments, we verified direct association between TP53 mutations and differential isoform expression in cell cycle genes. Additional iSoMAs genes have been validated in the literature with independent cohorts and/or methods. Despite the complexity of cancer, iSoMAs attains computational efficiency via dimension reduction strategy and reveals critical associations between regulatory factors and transcriptional landscapes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
- Microarrays and Single-Cell Genomics Core, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
ORCID-Profile: Hua Tan, Valer Gotea, Sushil K Jaiswal, Laura Elnitski
Förderung
- Intramural NIH HHS
- NHGRI NIH HHS
- Carlsberg Foundation
- NIH HHS
- National Human Genome Research Institute
- the Carlsberg Foundation
Zitieren
APA
Tan, H., Gotea, V., Jaiswal, S. K., Seidel, N. E., Holland, D. O., Fedkenheuer, K., Elkahloun, A. G., Bang-Christensen, S. R., & Elnitski, L. (2025). iSoMAs: Finding isoform expression and somatic mutation associations in human cancers. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1012847
Vancouver
Tan H, Gotea V, Jaiswal SK, Seidel NE, Holland DO, Fedkenheuer K, et al. iSoMAs: Finding isoform expression and somatic mutation associations in human cancers. PLOS Computational Biology. 2025. doi:10.1371/journal.pcbi.1012847
BibTeX
@article{Tan2025,
author = {Tan, Hua and Gotea, Valer and Jaiswal, Sushil K and Seidel, Nancy E and Holland, David O and Fedkenheuer, Kevin and Elkahloun, Abdel G and Bang-Christensen, Sara R and Elnitski, Laura},
title = {iSoMAs: Finding isoform expression and somatic mutation associations in human cancers},
journal = {PLOS Computational Biology},
year = {2025},
doi = {10.1371/journal.pcbi.1012847}
}
EUVIMED